Joel Greenblatt Gotham Asset Management
Joel Greenblatt is a co-founder of Gotham Asset Management and a well-known value investor, professor, and author. He gained wide recognition for The Little Book That Beats the Market and for popularizing a systematic value approach often called the “magic formula.” Greenblatt’s career spans special-situation investing, quantitative value strategies, and investor education.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$25.9M |
| 2 |
Automatic Data Processing
ADP
|
+$7.91M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$7.59M |
| 4 |
HES
Hess
HES
|
+$7.13M |
| 5 |
NLSN
Nielsen Holdings plc
NLSN
|
+$7.12M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
eBay
EBAY
|
+$8.9M |
| 2 |
TransDigm Group
TDG
|
+$8.9M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$7.17M |
| 4 |
Howmet Aerospace
HWM
|
+$6.82M |
| 5 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$6.35M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.35% |
| 2 | Consumer Discretionary | 14.2% |
| 3 | Industrials | 13.49% |
| 4 | Healthcare | 12.93% |
| 5 | Consumer Staples | 7.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Fortive
FTV
$18.3B
| $1.88M | 0.08% |
35,716
-72,347
| -67% | -$3.9M |
|
327
Cooper Companies
COO
$14.8B
| $1.87M | 0.08% |
18,856
+15,096
| +401% | +$1.48M |
|
328
Keysight
KEYS
$53.2B
| $1.87M | 0.08% |
12,083
+7,467
| +162% | +$1.08M |
|
329
Adient
ADNT
$1.45B
| $1.85M | 0.08% |
40,961
+9,245
| +29% | +$432K |
|
330
Dine Brands
DIN
$452M
| $1.84M | 0.08% |
20,636
-11,137
| -35% | -$1.03M |
|
331
Micron Technology
MU
$1.03T
| $1.84M | 0.08% |
21,660
+4,037
| +23% | +$341K |
|
332
Quanta Services
PWR
$93.2B
| $1.83M | 0.08% |
20,208
-63,553
| -76% | -$5.97M |
|
|
NUAN
333
DELISTED
Nuance Communications, Inc.
NUAN
| $1.83M | 0.08% |
33,581
+3,711
| +12% | +$196K |
|
334
Rollins
ROL
$18B
| $1.83M | 0.08% |
53,429
+19,300
| +57% | +$674K |
|
335
Williams-Sonoma
WSM
$28.2B
| $1.82M | 0.08% |
22,846
-1,698
| -7% | -$144K |
|
336
Aflac
AFL
$59.2B
| $1.82M | 0.08% |
33,904
+18,536
| +121% | +$1.01M |
|
337
United Therapeutics
UTHR
$22B
| $1.81M | 0.08% |
10,110
-9,054
| -47% | -$1.72M |
|
338
Avient
AVNT
$4.07B
| $1.8M | 0.08% |
36,714
-35,780
| -49% | -$1.81M |
|
339
ABM Industries
ABM
$2.75B
| $1.8M | 0.08% |
40,681
+4,241
| +12% | +$213K |
|
340
Bio-Rad Laboratories Class A
BIO
$10.1B
| $1.8M | 0.08% |
2,791
-3,233
| -54% | -$1.97M |
|
341
Leidos
LDOS
$17.4B
| $1.79M | 0.08% |
+17,666
| New | +$1.81M |
|
|
BECN
342
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $1.79M | 0.08% |
33,543
+24,521
| +272% | +$1.37M |
|
|
CERN
343
DELISTED
Cerner Corp
CERN
| $1.78M | 0.08% |
22,786
-28,970
| -56% | -$2.23M |
|
|
OPTU
344
Optimum Communications Inc
OPTU
$331M
| $1.77M | 0.08% |
51,808
+40,558
| +361% | +$1.42M |
|
345
Elastic
ESTC
$8.69B
| $1.76M | 0.07% |
+12,110
| New | +$1.51M |
|
346
Fair Isaac
FICO
$25.3B
| $1.76M | 0.07% |
3,505
+1,734
| +98% | +$877K |
|
347
Champion Homes
SKY
$4.93B
| $1.76M | 0.07% |
33,019
+18,944
| +135% | +$893K |
|
348
Teledyne Technologies
TDY
$29B
| $1.75M | 0.07% |
4,177
+2,411
| +137% | +$1.02M |
|
349
Campbell Soup
CPB
$7.2B
| $1.75M | 0.07% |
38,321
-24,325
| -39% | -$1.17M |
|
350
MasTec
MTZ
$20.7B
| $1.74M | 0.07% |
16,442
-5,482
| -25% | -$595K |
|
Similar funds
Joel Greenblatt's Q2 2021 Portfolio in Review
As of Q2 2021, Joel Greenblatt held 1,160 positions worth $2.36B, up 5.3% from $2.24B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Joel Greenblatt's Q2 2021 filing shows 181 new, 351 increased, 440 reduced and 178 closed positions. Its largest new stake was Vertex Pharmaceuticals: 36,305 shares worth $7.32M. The largest sale was eBay, an estimated $8.9M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Industrials.
- Joel Greenblatt's largest Q2 2021 buy was Vertex Pharmaceuticals: 36,305 shares worth $7.32M.
- Joel Greenblatt added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $25.9M increase.
- Joel Greenblatt's biggest Q2 2021 reduction was eBay, cutting an estimated $8.9M.
- Joel Greenblatt fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $6.35M.
- Joel Greenblatt's ten largest holdings make up 13% of its $2.36B portfolio in Q2 2021.
- Joel Greenblatt opened 181 new positions and closed 178 in Q2 2021.
- Joel Greenblatt's portfolio value rose 5.3% quarter-over-quarter to $2.36B.
Based on Gotham Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.